Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0EO5P
|
||||
Former ID |
DNC006821
|
||||
Drug Name |
1-(2-(2-ethylphenyl)-1-phenylethyl)piperazine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528224] | ||
Structure |
Download2D MOL |
||||
Formula |
C20H26N2
|
||||
Canonical SMILES |
CCC1=CC=CC=C1CC(C2=CC=CC=C2)N3CCNCC3
|
||||
InChI |
1S/C20H26N2/c1-2-17-8-6-7-11-19(17)16-20(18-9-4-3-5-10-18)22-14-12-21-13-15-22/h3-11,20-21H,2,12-16H2,1H3
|
||||
InChIKey |
USQDYFAONFKQLW-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Sodium-dependent noradrenaline transporter | Target Info | Inhibitor | [528224] | |
Sodium-dependent serotonin transporter | Target Info | Inhibitor | [528224] | ||
KEGG Pathway | Serotonergic synapse | ||||
NetPath Pathway | TCR Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.